鍋倉 宰
Nabekura, Tsukasa
愛知県がんセンター 研究所 , 腫瘍免疫応答研究分野 , 分野長 Aichi Cancer Center, Research Institute , Division of Immune Response , Chief
-
1.
Tn antigen suppresses lipopolysaccharide-induced dermatitis via Clec10a
Katsunobu Shigematsu; Kenshiro Matsuda; Tsukasa Nabekura; Kazumasa Kanemaru (+2 著者) Akira Shibuya
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 772: 152024 (2025)
-
2.
1. CD96 enhances the anti-viral activity of natural killer cells by promoting Ly49H-mediated activation during mouse cytomegalovirus infection
Nabekura,Tsukasa; Matsuo,Soichi; Shibuya,Kazuko; Shibuya,Akira
MOLECULAR IMMUNOLOGY 179: 65 (2025)
-
3.
Immunological memory in natural killer cells
Nabekura,Tsukasa
INTERNATIONAL IMMUNOLOGY (2025)
-
4.
NK細胞の免疫記憶
鍋倉 宰
臨床免疫・アレルギー科 82: (2024)
-
5.
Concanavalin A-induced acute liver injury in mice
Nabekura,Tsukasa; Matsuo,Soichi; Shibuya,Akira
CURRENT PROTOCOLS 4: e1117 (2024)
-
6.
THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling
Deborah, Elfira Amalia; Nabekura, Tsukasa; Shibuya, Kazuko; Shibuya, Akira
JOURNAL OF IMMUNOLOGY 212: 1819 (2024)
-
7.
Themis2 regulates natural killer cell memory function and formation
Nabekura, Tsukasa; Deborah; Elfira Amalia; Tahara, Saeko (+5 著者) Shibuya, Akira
NATURE COMMUNICATIONS 14: 7200 (2023) Semantic Scholar
-
8.
DNAM-1 immunoreceptor protects mice from concanavalin A-induced acute liver injury by reducing neutrophil infiltration.
Matsuo, Soichi; Nabekura, Tsukasa; Matsuda, Kenshiro; Shibuya, KazukoShibuya, Akira
JOURNAL OF IMMUNOLOGY 211: 954 (2023)
-
9.
Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches
Asahi, Takuma; Abe, Shinya; Cui, Guangwei; Shimba, Akihiro (+8 著者) Ikuta, Koichi
ELIFE 12: e84209 (2023) Semantic Scholar
-
10.
The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells
Aguilar, Oscar A.; Gonzalez-Hinojosa; Maria D R.; Arakawa-Hoy (+4 著者) Lanier, Lewis L.
JOURNAL OF LEUKOCYTE BIOLOGY 113: 27 (2023) Semantic Scholar
-
11.
Early reactivation of clustered genes on the inactive X chromosome during somatic cell reprogramming
Aizawa, Shiho; Nishimura, Ken; Mondejar; Gonzalo Seminario (+12 著者) Hisatake, Koji
STEM CELL REPORTS 17: 53 (2022) Semantic Scholar
-
12.
Selective expression of a C-type lectin receptor, Clec12b, on skin mast cells
Iijima, Ayana; Kanemaru, Kazumasa; Wang, Yaqiu; Nabekura, Tsukasa (+6 著者) Shibuya, Akira
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 561: 101 (2021) Semantic Scholar
-
13.
Type 1 innate lymphoid cells: Soldiers at the front line of immunity
Tsukasa Nabekura; Akira Shibuya
BIOMEDICAL JOURNAL 44: 115 (2021) Semantic Scholar
-
14.
ILC1: guardians of the oral mucosa against enemy viruses
Nabekura, Tsukasa; Shibuya, Akira
IMMUNITY 54: 196 (2021) Semantic Scholar
-
15.
1型自然リンパ球が急性肝障害において、保護的な役割を持つ
鍋倉 宰; 渋谷 彰
感染・炎症・免疫 51: 54 (2021)
-
16.
急性肝障害とILC1
松尾 壯一; 鍋倉 宰; 渋谷 彰
臨床免疫・アレルギー科 76: 581 (2021)
-
17.
1型自然リンパ球は急性肝障害において保護的な役割を持つ
鍋倉 宰; 渋谷 彰
医学のあゆみ 276: 730 (2021)
-
18.
ImmGen at 15
Stephanie Vargas Aguilar; Oscar Aguilar; Rhys Allan; El Ad David Amir (+218 著者) Caroline Ziemkiewicz
NATURE IMMUNOLOGY 21: 700 (2020) Semantic Scholar
-
19.
Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes
Nabekura, Tsukasa; Riggan, Luke; Hildreth, Andrew D; O’Sullivan (+1 著者) Shibuya, Akira
IMMUNITY 52: 96 (2020) Semantic Scholar
-
20.
The cis-Regulatory Atlas of the Mouse Immune System
Yoshida, Hideyuki; Lareau, Caleb A; Ramirez, Ricardo N; Rose, Samuel A (+22 著者) Project, Immunological Genome
Cell 176: 897-912.e20 (2019) Semantic Scholar
-
1.
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
鍋倉, 宰
2008年3月
-
41.
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
Nabekura,Tsukasa
第37回日本免疫学会学術集会 2007年11月
-
42.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第13回日本遺伝子治療学会学術集会 2007年6月
-
43.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第36回日本免疫学会学術集会 2006年12月
-
44.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第12回日本遺伝子治療学会学術集会 2006年8月
-
45.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第35回日本免疫学会学術集会 2005年12月
-
46.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第11回日本遺伝子治療学会学術集会 2005年7月
-
47.
Potent cancer immunotherapy with dendritic cells generated from genetically modified hematopoietic stem cells
Nabekura,Tsukasa
The 7th Annual Meeting of the American Society of Gene Therapy 2004年6月
-
48.
Establishment of a novel cancer immunotherapy with genetically modified dendritic cells.
Nabekura,Tsukasa
第33回日本免疫学会学術集会 2003年12月
-
49.
The scaffold protein Themis2 limits natural killer memory formation during mouse cytomegalovirus infection
Nabekura, Tsukasa
International Symposium on Immune Regulation 招待有り
-
1. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
2. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
3. : ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
渋谷 彰; 小田 ちぐさ; 田原 聡子; Nabekura, Tsukasa; カンカーナム ガマゲ; サナトゥ ウダヤンガ; 三木 春香; 飯野 秀一 -
4. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
5. : ベクターによる遺伝子改変型樹状細胞を用いた抗体作製方法
小野寺, 雅史; 大津, 真; 鍋倉, 宰 -
6. : レトロウイルスを用いて改変された細胞を用いた養子免疫遺伝子細胞治療
小野寺, 雅史; 濱仲, 早苗; 鍋倉, 宰; 中内, 啓光 -
7. : ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
渋谷 彰; 小田 ちぐさ; 田原 聡子; 鍋倉 宰; カンカーナム ガマゲ; サナトゥ ウダヤンガ; 三木 春香; 飯野 秀一 -
8. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
9. 特願2013-545868: 活性調節剤、これを含有する医薬品、および抗CD300a抗体
渋谷, 彰; 小田 ちぐさ; 田原 聡子; 鍋倉 宰; カンカーナム ガマゲ; サナトゥ ウダヤンガ; 三木 春香; 飯野 秀一 -
10. 特開2014-095570: セリアック病に関連する、CD300a遺伝子欠損マウスおよびCD300a発現細胞の活性調節剤の使用、ならびにCD300a発現細胞の活性調節剤を含有する医薬品
渋谷,彰; 小田 ちぐさ; 鍋倉 宰 -
11. WO/2013/077186: Activity modulator, medical agent comprising same, use of CD300a gene-deficient mouse, and anti-CD330a antibody
鍋倉,宰
864 total views